CVII stock icon

Churchill Capital Corp VII
CVII

$10.78
0.09%
 

About: Churchill Capital Corp VII is a blank check company.

Employees: 2

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

1% more capital invested

Capital invested by funds: $592M [Q4 2023] → $595M (+$3.47M) [Q1 2024]

1.36% less ownership

Funds ownership: 97.21% [Q4 2023] → 95.85% (-1.36%) [Q1 2024]

12% less funds holding

Funds holding: 58 [Q4 2023] → 51 (-7) [Q1 2024]

25% less funds holding in top 10

Funds holding in top 10: 8 [Q4 2023] → 6 (-2) [Q1 2024]

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

72% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $171K

Research analyst outlook

We haven’t received any recent analyst ratings for CVII.

Financial journalist opinion

Neutral
PRNewsWire
13 hours ago
Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024
Board of Directors Recommends Stockholders and Public Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England , June 20, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") to be held in connection with the proposed business combination (the "Business Combination") between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII and a meeting of Churchill VII public warrant holders (the "Warrant Holder Meeting"), each for July 25, 2024. Churchill VII stockholders and public warrant holders of record as of the close of business on June 18, 2024 (the "Record Date") will receive the definitive proxy statement/prospectus, once available (the "Proxy Statement") relating to the offer of the securities to be issued by CorpAcq Group Plc to Churchill VII's stockholders and public warrant holders in connection with the completion of the Business Combination by mail and are entitled to vote at the Stockholder Special Meeting and/or Warrant Holder Meeting, respectively.
Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024